More people are getting COVID-19 twice, suggesting immunity wanes quickly in some – Science
The post More people are getting COVID-19 twice, suggesting immunity wanes quickly in some appeared first on Links Medicus.
Pfizer and BioNTech to submit Covid-19 vaccine data to FDA as full results show 95% efficacy – STAT News release: Pfizer and Biontech conclude phase 3 study of Covid-19 vaccine candidate, meeting all primary efficacy endpoints Commentaries: ‘Incredible milestone for science.’ Pfizer and BioNTech update their promising COVID-19 vaccine result – Science AND Pfizer: COVID-19 […]
The post Pfizer and BioNTech to submit Covid-19 vaccine data to FDA as full results show 95% efficacy appeared first on Links Medicus.
Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline – American Journal of Respiratory and Critical Care Medicine Commentary: Home Oxygen Therapy for Adults with COPD and ILD: New ATS Clinical Practice Guideline – American Thoracic Society
The post ATS Guideline: Home oxygen therapy for adults with chronic lung disease appeared first on Links Medicus.
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial – The Lancet Commentaries: Covid-19: Chinese vaccine ‘successful in mid-stage trials’ – BBC AND Expecting the unexpected with COVID-19 vaccines – The Lancet Infectious Diseases Commentary on Twitter NEW—Chinese #COVID19 vaccine […]
The post Chinese Covid-19 vaccine candidate (CoronaVac) appears safe and induces an immune response in healthy volunteers in phase 1/2 clinical trial appeared first on Links Medicus.
Immunological memory to SARS-CoV-2 assessed for greater than six months after infection – bioRxiv Commentaries: Immunity to the Coronavirus May Last Years, New Data Hint – New York Times AND Could coronavirus immunity last YEARS? Study finds even survivors who had mild COVID-19 are protected for at least 8 months and their immune ‘memory’ may […]
The post [Preprint] Study suggests immunity to the Coronavirus may last years appeared first on Links Medicus.
Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies – CHEST Editorial: Management of Community-Acquired Pneumonia in Immunocompromised Adults – CHEST
The post Treatment of community-acquired pneumonia in immunocompromised adults: A consensus statement regarding initial strategies appeared first on Links Medicus.
Prone positioning for patients with hypoxic respiratory failure related to COVID-19 – Canadian Medical Association Journal Commentary on Twitter What's the evidence for prone positioning for patients with respiratory distress related to #COVID19? A new review answers pressing questions about this common intervention: https://t.co/dh15AuUpD0 #ICU #CriticalCare pic.twitter.com/Y8TzactS70 — CMAJ (@CMAJ) November 11, 2020
The post Review: Prone positioning for patients with hypoxic respiratory failure related to COVID-19 appeared first on Links Medicus.
Characteristics of Hospitalized COVID-19 Patients Discharged and Experiencing Same-Hospital Readmission — United States, March–August 2020 – CDC Morbidity and Mortality Weekly Report Commentary: 9 percent readmitted after index COVID-19 hospitalization – MedicalXpress AND One in 11 coronavirus patients discharged from a hospital is readmitted within two months, suggesting long-lasting effects of the infection, CDC report […]
The post CDC Report: 9% readmitted after Covid-19 hospitalization. Risk factors were age ≥65 y, chronic medical conditions, recent hospitalization before Covid-19, and discharge to a skilled nursing facility or with home health care appeared first on Links Medicus.
Press release: Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study See also: Moderna Announces Longer Shelf Life for its COVID-19 Vaccine Candidate at Refrigerated Temperatures Commentaries: What Moderna’s Covid-19 vaccine results mean for ending the pandemic – Vox AND Moderna follows Pfizer with […]
The post [Press release – not published yet] Moderna’s COVID-19 vaccine candidate shows 94.5% protection in an interim analysis of the phase 3 COVE study appeared first on Links Medicus.
Evidence-Based Practices for Acute Respiratory Failure and Acute Respiratory Distress Syndrome – CHEST Commentary: Best practices for mechanical ventilation in patients with ARDS, COVID-19 – University of Michigan
The post Systematic review: Evidence-based practices for acute respiratory failure and Acute Respiratory Distress Syndrome appeared first on Links Medicus.